Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 17-Nov-23 5:03 PM View:  | Vyne Therapeutics Inc. (VYNE) | 15-Nov-23 | Purchase | 13,000 | $3.91 | $50,778.00 | 55% 23.47K to 36.47K | |
| 22-Mar-23 4:03 PM View: | Vyne Therapeutics Inc. (VYNE) | 20-Mar-23 | Purchase | 20,000 | $2.48 | $49,680.00 | 576% 3.47K to 23.47K | |
| 14-Nov-22 4:16 PM View: | Lannett Co. Inc. (LCI) | 10-Nov-22 | Private Purchase | 100,000 | $0.49 | $49,000.00 | 21% 487.14K to 587.14K | |
| 17-May-22 4:16 PM View: | Lannett Co. Inc. (LCI) | 16-May-22 | Private Purchase | 50,000 | $0.54 | $27,000.00 | 11% 437.14K to 487.14K | |
| 10-Feb-22 5:17 PM View: | Lannett Co. Inc. (LCI) | 08-Feb-22 | Private Purchase | 50,000 | $0.88 | $44,000.00 | 13% 387.14K to 437.14K | |
| 02-Dec-21 5:08 PM View: | Vyne Therapeutics Inc. (VYNE) | 30-Nov-21 | Market Purchase (Planned) | 12,500 | $1.02 | $12,698.80 | 25% 50.0K to 62.5K | (6%) |
| 30-Nov-21 4:05 PM View: | Lannett Co. Inc. (LCI) | 29-Nov-21 | Market Purchase | 50,000 | $1.71 | $85,500.00 | 15% 337.14K to 387.14K | (4%) |
| 09-Sep-21 10:00 PM View: | Lannett Co. Inc. (LCI) | 08-Sep-21 | Market Purchase | 20,000 | $3.31 | $66,200.00 | 6% 317.14K to 337.14K | < 1% |
| 26-Aug-21 5:04 PM View: | Vyne Therapeutics Inc. (VYNE) | 25-Aug-21 | Market Purchase | 12,500 | $1.60 | $20,000.00 | 33% 37.5K to 50.0K | (1%) |
| 27-May-21 5:18 PM View: | Vyne Therapeutics Inc. (VYNE) | 26-May-21 | Market Purchase | 12,500 | $3.60 | $44,957.50 | 50% 25.0K to 37.5K | < 1% |
| 12-May-21 4:50 PM View: | Lannett Co. Inc. (LCI) | 11-May-21 | Market Purchase | 20,000 | $4.18 | $83,600.00 | 8% 240.33K to 260.33K | (< 1%) |
| 16-Mar-21 4:38 PM View: | Vyne Therapeutics Inc. (VYNE) | 15-Mar-21 | Market Purchase | 12,500 | $7.41 | $92,562.50 | 100% 12.5K to 25.0K | (1%) |
| 07-Dec-20 4:31 PM View: | Vyne Therapeutics Inc. (VYNE) | 03-Dec-20 | Market Purchase (Planned) | 50,000 | $1.71 | $85,425.00 | 100% 0 to 50.0K | 4% |
| 03-Sep-20 4:25 PM View: | Lannett Co. Inc. (LCI) | 01-Sep-20 | Grant | 38,986 | -- | -- | 19% 201.34K to 240.33K | |
| 18-May-20 10:00 AM View: | Matinas Biopharma Holdings,... (MTNB) | 14-May-20 | Market Purchase | 100,000 | $0.73 | $73,050.00 | 33% 300.0K to 400.0K | 33% |
| 19-Nov-19 10:00 AM View: | Matinas Biopharma Holdings,... (MTNB) | 15-Nov-19 | Market Purchase | 100,000 | $1.06 | $105,530.00 | 50% 200.0K to 300.0K | (6%) |
| 05-Sep-19 4:15 PM View: | Lannett Co. Inc. (LCI) | 03-Sep-19 | Market Purchase | 25,000 | $9.82 | $245,500.00 | 14% 176.34K to 201.34K | (32%) |
| 20-Aug-19 10:02 AM View: | Matinas Biopharma Holdings,... (MTNB) | 16-Aug-19 | Market Purchase | 100,000 | $0.72 | $71,850.00 | 100% 100.0K to 200.0K | 29% |
| 22-Jul-19 4:25 PM View: | Lannett Co. Inc. (LCI) | 19-Jul-19 | Grant | 33,445 | -- | -- | 23% 142.9K to 176.34K | |
| 20-May-19 6:39 PM View: | Matinas Biopharma Holdings,... (MTNB) | 16-May-19 | Market Purchase | 100,000 | $0.95 | $95,250.00 | 100% 0 to 100.0K | (< 1%) |
| 09-May-19 4:21 PM View: | Lannett Co. Inc. (LCI) | 08-May-19 | Market Purchase | 25,000 | $7.32 | $183,000.00 | 21% 117.89K to 142.9K | (9%) |
| 13-Feb-19 10:00 PM View: | Lannett Co. Inc. (LCI) | 12-Feb-19 | Market Purchase | 25,000 | $8.93 | $223,250.00 | 27% 92.89K to 117.89K | (26%) |
| 17-Dec-18 11:14 AM View: | Lannett Co. Inc. (LCI) | 13-Dec-18 | Market Purchase | 25,000 | $5.10 | $127,500.00 | 37% 67.89K to 92.89K | 30% |
| 04-Sep-18 4:19 PM View: | Lannett Co. Inc. (LCI) | 31-Aug-18 | Market Purchase | 25,000 | $5.34 | $133,500.00 | 58% 42.9K to 67.89K | 24% |
| 23-Jul-18 6:19 PM View: | Lannett Co. Inc. (LCI) | 20-Jul-18 | Grant | 16,195 | -- | -- | 61% 26.7K to 42.9K | |
| 14-May-18 4:12 PM View: | Lannett Co. Inc. (LCI) | 11-May-18 | Market Purchase | 25,000 | $15.13 | $378,250.00 | 1471% 1.7K to 26.7K | (56%) |
| 08-Dec-17 5:16 PM View: | PharMerica Corporation (PMC) | 07-Dec-17 | Disposition | 29,570 | $29.25 | $864,922.00 | (100%) 29.57K to 0 | |
| 16-Jun-17 4:43 PM View: | PharMerica Corporation (PMC) | 14-Jun-17 | Grant | 4,817 | -- | -- | 19% 24.75K to 29.57K | |
| 24-Apr-17 5:06 PM View: | Theravance Inc. (INVA) | 20-Apr-17 | Grant | 19,857 | -- | -- | 52% 38.42K to 58.28K | |
| 27-Oct-16 6:31 PM View: | Theravance Inc. (INVA) | 26-Oct-16 | Grant | 38,421 | -- | -- | 100% 0 to 38.42K | |
| 21-Jun-16 4:39 PM View: | PharMerica Corporation (PMC) | 17-Jun-16 | Grant | 5,167 | -- | -- | 26% 19.59K to 24.75K | |
| 23-Jun-15 4:50 PM View: | PharMerica Corporation (PMC) | 19-Jun-15 | Grant | 3,730 | -- | -- | 24% 15.86K to 19.59K | |
| 18-Jun-14 4:07 PM View: | PharMerica Corporation (PMC) | 17-Jun-14 | Grant | 4,300 | -- | -- | 37% 11.56K to 15.86K | |
| 19-Jun-13 4:59 PM View: | PharMerica Corporation (PMC) | 17-Jun-13 | Grant | 5,685 | -- | -- | 95% 6.0K to 11.69K | |
| 14-Jan-13 6:48 PM View: | PharMerica Corporation (PMC) | 14-Jan-13 | Grant | 6,000 | -- | -- | 100% 0 to 6.0K | |
| 02-Oct-12 5:00 PM View: | Par Pharmaceutical Companie... (PRX) | 28-Sep-12 | Disposition | 191,792 | $50.00 | $9,589,600.00 | (83%) 229.79K to 38.0K | |
| 02-Oct-12 5:00 PM View: | Par Pharmaceutical Companie... (PRX) | 28-Sep-12 | Disposition | 38,000 | $50.00 | $1,900,000.00 | (100%) 38.0K to 0 | |
| 13-Jan-12 5:02 PM View: | Par Pharmaceutical Companie... (PRX) | 11-Jan-12 | Payment of Exercise | 1,652 | $35.65 | $58,893.80 | (< 1%) 231.44K to 229.79K | (< 1%) |
| 11-Jan-12 5:50 PM View: | Par Pharmaceutical Companie... (PRX) | 09-Jan-12 | Payment of Exercise | 5,365 | $35.09 | $188,258.00 | (2%) 236.81K to 231.44K | (3%) |
| 06-Jan-12 5:19 PM View: | Par Pharmaceutical Companie... (PRX) | 04-Jan-12 | Payment of Exercise | 2,941 | $32.17 | $94,612.00 | (1%) 239.75K to 236.81K | (2%) |
| 07-Sep-11 2:39 PM View: | Par Pharmaceutical Companie... (PRX) | 06-Sep-11 | Market Purchase | 8,000 | $25.92 | $207,360.00 | 3% 284.88K to 292.88K | 4% |
| 10-Aug-11 5:26 PM View: | Par Pharmaceutical Companie... (PRX) | 09-Aug-11 | Payment of Exercise | 8,690 | $29.09 | $252,792.00 | (3%) 293.57K to 284.88K | 0% |
| 11-May-11 4:34 PM View: | Par Pharmaceutical Companie... (PRX) | 09-May-11 | Option Exercise | 65,467 | $13.06 | $854,999.00 | 22% 293.57K to 359.04K | |
| 11-May-11 4:34 PM View: | Par Pharmaceutical Companie... (PRX) | 09-May-11 | Market Option Sale | 65,467 | $34.17 | $2,236,970.00 | (18%) 359.04K to 293.57K | (4%) |
| 24-Mar-11 5:32 PM View: | Par Pharmaceutical Companie... (PRX) | 22-Mar-11 | Payment of Exercise | 2,455 | $29.00 | $71,195.00 | (< 1%) 296.02K to 293.57K | < 1% |
| 13-Jan-11 6:04 PM View: | Par Pharmaceutical Companie... (PRX) | 11-Jan-11 | Grant | 27,004 | -- | -- | 9% 294.06K to 321.07K | |
| 13-Jan-11 6:04 PM View: | Par Pharmaceutical Companie... (PRX) | 11-Jan-11 | Payment of Exercise | 26,796 | $35.98 | $964,120.00 | (8%) 321.07K to 294.27K | < 1% |
| 12-Jan-11 4:26 PM View: | Par Pharmaceutical Companie... (PRX) | 10-Jan-11 | Payment of Exercise | 5,365 | $36.00 | $193,140.00 | (2%) 299.43K to 294.06K | < 1% |
| 10-Jan-11 5:38 PM View: | Par Pharmaceutical Companie... (PRX) | 06-Jan-11 | Grant | 50,491 | -- | -- | 20% 250.55K to 301.04K | |
| 06-Jan-11 5:48 PM View: | Par Pharmaceutical Companie... (PRX) | 04-Jan-11 | Payment of Exercise | 2,940 | $39.79 | $116,983.00 | (1%) 253.49K to 250.55K | 4% |